Long-Term Impact of Endoscopic Thoracic Sympathectomy for Primary Palmar Hyperhidrosis.

Document Type

Article

Publication Date

6-7-2018

Publication Title

The Annals of thoracic surgery

Abstract

BACKGROUND: Endoscopic thoracic sympathectomy (ETS) is the gold standard treatment for primary hyperhidrosis, with excellent short-term results. The potential for adverse effects, particularly compensatory sweating (CS), may affect long-term satisfaction. In this retrospective review we aimed to examine the long-term results, and quality of life (QOL) following ETS in the management of primary, dominantly palmar hyperhidrosis from a single institution.

METHODS: A review of patients who had undergone ETS for primary palmar or axillary hyperhidrosis between 02/2004-05/2015 was performed. Utilizing a modified questionnaire with validated components, patients were contacted to obtain responses designed to measure outcomes and QOL domains.

RESULTS: Of the 96 eligible patients, 58 (60%) consented and completed the questionnaire. The median time of survey from surgery was 60 months (interquartile range: 35-122). Increased QOL was reported in 84% (49/58) of patients, and increased ability to perform tasks in 86% (50/58). Satisfaction was identified in 97% (56/58) of patients, and 93% (54/58) reported that they would recommend the procedure. CS was reported in 84% (49/58), ranging from minor 78% (38/49) to severe 22% (11/49). There were 146 total CS areas involved, most commonly the back (78%, 38/49). One ETS reversal, for extreme CS, was performed. Nonetheless, 78% (38/49) reported CS to be less disruptive than preoperative hyperhidrosis.

CONCLUSIONS: This study confirms that the benefits of ETS are maintained long-term. Although CS is the main cause for discontent postoperatively, it is still preferred over the distress experienced from palmar or axillary hyperhidrosis and QOL is increased despite CS.

Department

Surgery

Link to Full Text

PSJH Full Text

Share

COinS